Literature DB >> 26064312

Down-regulation of microRNA-26b rescued hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes by regulating PTEN.

Xiaoyu Wang1, Chen Li1, Qiaoqun Dai2.   

Abstract

BACKGROUND: Cardiomyocyte hypoxia causes cardiac hypertrophy and other major myocardial injuries. We investigated the molecular mechanism of microRNA-26b (miR-26b) in regulating hypoxia-induced apoptosis in rat neonatal cardiomyocytes.
METHODS: Neonatal rat cardiomyocytes was prepared in vitro and hypoxia was induced. Apoptotic cardiomyocytes were examined by TUNEL staining and the expression of miR-26b were monitored by qRT-PCR. The effect of mir-26b downregulation on hypoxia-induced apoptosis, or expression of PTEN in cardiomyocytes was monitored. PTEN was knocked down in cardiomyocytes by siRNA to further investigate its association with miR-26b.
RESULTS: Hypoxia induced severe apoptosis and upregulated miR-26b in neonatal rat cardiomyocytes in vitro. Down-regulation of miR-26b markedly ameliorated hypoxia-induced apoptosis and up-regulated PTEN. Luciferase reporter assay confirmed PTEN was directly targeted by miR-26b, and knocking down PTEN reduced cytotoxicity induced by miR-26b upregulation.
CONCLUSION: Downregulation of miR-26b protected cardiomyocytes from hypoxia-induced apoptosis, and the protective effect was very likely to be associated with PTEN regulation.

Entities:  

Keywords:  Cardiomyocytes; PTEN; hypoxia; miR-26b

Year:  2015        PMID: 26064312      PMCID: PMC4443146     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

Review 1.  MicroRNA expression and function in cardiac ischemic injury.

Authors:  Shiyong Yu; Guohong Li
Journal:  J Cardiovasc Transl Res       Date:  2010-06       Impact factor: 4.132

Review 2.  Role of microRNAs in cardiac hypertrophy and heart failure.

Authors:  Nan Wang; Zhen Zhou; Xinghua Liao; Tongcun Zhang
Journal:  IUBMB Life       Date:  2009-06       Impact factor: 3.885

3.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 4.  Cardiomyocyte apoptosis in acute and chronic conditions.

Authors:  B Freude; T N Masters; S Kostin; F Robicsek; J Schaper
Journal:  Basic Res Cardiol       Date:  1998-04       Impact factor: 17.165

5.  Apoptosis is initiated by myocardial ischemia and executed during reperfusion.

Authors:  B Freude; T N Masters; F Robicsek; A Fokin; S Kostin; R Zimmermann; C Ullmann; S Lorenz-Meyer; J Schaper
Journal:  J Mol Cell Cardiol       Date:  2000-02       Impact factor: 5.000

6.  The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival.

Authors:  G Schwartzbauer; J Robbins
Journal:  J Biol Chem       Date:  2001-07-11       Impact factor: 5.157

Review 7.  Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary.

Authors:  Joseph S Alpert; Kristian A Thygesen; Harvey D White; Allan S Jaffe
Journal:  Am J Med       Date:  2013-10-16       Impact factor: 4.965

8.  MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target.

Authors:  Zhen-hui Zhang; Jiao Li; Ben-rong Liu; Cheng-feng Luo; Qi Dong; Lu-ning Zhao; Yun Zhong; Wei-yan Chen; Min-sheng Chen; Shi-ming Liu
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

Review 9.  microRNA: emerging therapeutic targets in acute ischemic diseases.

Authors:  Pasquale Fasanaro; Simona Greco; Mircea Ivan; Maurizio C Capogrossi; Fabio Martelli
Journal:  Pharmacol Ther       Date:  2009-11-06       Impact factor: 12.310

10.  Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes.

Authors:  M Tanaka; H Ito; S Adachi; H Akimoto; T Nishikawa; T Kasajima; F Marumo; M Hiroe
Journal:  Circ Res       Date:  1994-09       Impact factor: 17.367

View more
  5 in total

1.  Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p.

Authors:  Yong Wang; Baocun Sun; Huizhi Sun; Xiulan Zhao; Xudong Wang; Nan Zhao; Yanhui Zhang; Yanlei Li; Qiang Gu; Fang Liu; Bing Shao; Jindan An
Journal:  Tumour Biol       Date:  2016-02-18

2.  LncRNA260-specific siRNA targeting IL28RA gene inhibit cardiomyocytes hypoxic/reoxygenation injury.

Authors:  Ge Gong; Xin-Xing Yang; Yanyan Li; Hong-Yu Geng; Zhi-Jian Yang; Lian-Sheng Wang; Hyun Jun Kim; Xin-Zheng Lu
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

3.  Effect of HIF-1α/miR-10b-5p/PTEN on Hypoxia-Induced Cardiomyocyte Apoptosis.

Authors:  Liping Wu; Yafen Chen; Yuanyuan Chen; Wenbo Yang; Yanxin Han; Lin Lu; Ke Yang; Jiumei Cao
Journal:  J Am Heart Assoc       Date:  2019-09-04       Impact factor: 5.501

4.  A novel hypoxia-induced miR-147a regulates cell proliferation through a positive feedback loop of stabilizing HIF-1α.

Authors:  Fan Wang; Haoxiang Zhang; Naihan Xu; Nunu Huang; Caiming Tian; Anlin Ye; Guangnan Hu; Jie He; Yaou Zhang
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

5.  Conserved miR-26b enhances ovarian granulosa cell apoptosis through HAS2-HA-CD44-Caspase-3 pathway by targeting HAS2.

Authors:  Jiying Liu; Fei Tu; Wang Yao; Xinyu Li; Zhuang Xie; Honglin Liu; Qifa Li; Zengxiang Pan
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.